Jean-baptiste B. Hiriart

Bordeaux, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease.

Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease.

Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: July 28, 2025

Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study.

Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 16, 2025

Pneumocystis jirovecii pneumonia after liver transplantation in France: retrospective multicenter case series and survey on prophylaxis use.

Pneumocystis jirovecii pneumonia after liver transplantation in France: retrospective multicenter case series and survey on prophylaxis use.

Journal: Infectious diseases now
Published: April 08, 2025

Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial.

Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial.

Journal: The lancet. Gastroenterology & hepatology
Published: March 28, 2025

Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A French National Cohort Study Including 571 Patients.

Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A French National Cohort Study Including 571 Patients.

Journal: The American journal of gastroenterology
Published: February 28, 2025

Bariatric surgery and liver transplantation, here we are now: A French nationwide retrospective study.

Bariatric surgery and liver transplantation, here we are now: A French nationwide retrospective study.

Journal: Clinics and research in hepatology and gastroenterology
Published: March 07, 2023

Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study.

Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Published: February 27, 2023

Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis.

Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis.

Journal: JHEP reports : innovation in hepatology
Published: July 23, 2022

Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival.

Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 16, 2022

Silencing of RND3/RHOE inhibits the growth of human hepatocellular carcinoma and is associated with reversible senescence.

Silencing of RND3/RHOE inhibits the growth of human hepatocellular carcinoma and is associated with reversible senescence.

Journal: Cancer gene therapy
Published: August 24, 2021

Long-term prognosis of patients with metabolic (dysfunction)-associated fatty liver disease by non-invasive methods.

Long-term prognosis of patients with metabolic (dysfunction)-associated fatty liver disease by non-invasive methods.

Journal: Alimentary pharmacology & therapeutics
Published: July 13, 2021

Long-term prognosis of patients with alcohol-related liver disease or non-alcoholic fatty liver disease according to metabolic syndrome or alcohol use.

Long-term prognosis of patients with alcohol-related liver disease or non-alcoholic fatty liver disease according to metabolic syndrome or alcohol use.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 30, 2021
Showing 1-12 of 34

Last Updated: 09/26/2026